Recombinant Antibody Production Services

Recombinant Antibody Production Service Description

Sino Biological has a professional mammalian cell expression platform with more than 10 years of process optimization and production experience, providing one-stop services from gene synthesis to high-quality antibody production. For the past 10 years, Sino Biological has provided thousands of antibodies production service to customers worldwide and has established good cooperation relationships with world's leading pharmaceutical companies. Sino Biological is the preferred antibody production service provider for Top10 pharmaceutical companies worldwide.

Recombinant Antibody Production Service Types

Cases Studies of Recombinant Antibody Production Service

Sino Biological Inc. can achieve rapid and high-throughput recombinant antibody production. The preparation cycle is only 2-6 weeks, and the monomer purity can reach 99%.

Case study of recombinant antibody A production

  • SEC-HPLC >99%

Recombinant Antibody Production Service Highlights

Capacity and technology platform
? >20 shakers, >800 bottles culture capacity weekly
? >100 bioreactors (2L~1000L)
? Cell culture capacity: >50,000 L yearly
? Free codon optimization
? Optimized high-efficiency expression vectors
? Optimized proprietary culture medium
? Optimized mammalian cell expression platform
Rich experience ? Experienced in expressing different kinds of antibodies:
scFv antibody, Fab antibody, full length antibody, chimeric antibody, bispecific antibody, multi-chains co-transfection and expression, etc.
? Experienced in expressing and purifying multi-isotypes antibodies:
Human IgG1, IgG2, IgG3, IgG4
Mouse IgG1, IgG2a, IgG2b, IgG3
Rat IgG1, IgG2a, IgG2b, IgG2c
Rabbit IgG
Canine IgG
IgA, IgM, IgE
High quality ? High monomer purity: up to 99%
? Low endotoxin level: as low as 0.1 EU/mg
? Comprehensive quality control analysis:
UV, SDS-PAGE, ELISA, qPCR, SEC-HPLC, CEX-HPLC, LC-MS/MS, CE-SDS, ADCC,CDC, OCTET Affinity, Kinetics, off-rate, ranking

Well-established Recombinant Antibody Production Service Platforms

Contact Us

彩票大奖得主捐赠 资产配置的基本策略包括 配资返佣 福彩排列7历年开奖结果 北京快乐8预测软件 股票期货平台 北京快3几点到几点 吉林快三 双色球专家精选一注 36选7开奖顺序 2019长线股票推荐